Between now and the start of the 2025 NFL draft, there is going to be plenty of debate about who the best quarterback ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial results. "This is ...

HISD remained behind the national average and fell back in elementary reading scores but improved in most MAP score ...

Below are seven charts that illustrate key aspects of the 2024 presidential election. Inflation and high living costs are major issues for voters. Even though inflation rates have dropped since the ...

The FDA has acknowledged that data from the ongoing Phase 1/2 STAAR trial could serve as the primary evidence for an accelerated approval process. This development could lead to a faster and more cost ...

The FDA has acknowledged that data from the ongoing Phase 1/2 STAAR trial could serve as the primary evidence for an accelerated approval process. This development could lead to a faster and more ...

BIGBANG’s G-Dragon is back—and topping music charts across the globe! On October 31 at 6 p.m. KST, G-Dragon made his long-awaited solo return with his new pre-release single “POWER.” ...

Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates. Looking ahead, revenue ...

STAAR Surgical Company beats earnings expectations ... we generated sales growth of 9% in the third quarter. China sales were up 7% and ICL unit growth was positive. However, the high season ...

After bizarrely teasing a 9000-series X3D announcement last week, AMD is making it official today that the Ryzen 7 9800X3D will be available on November 7th. Priced at $479, the 9800X3D is a ...

We wrap up our coverage of the markets and the week. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...